Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Abstract

Impulse control disorders in Parkinson's disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies, including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, nonpharmacological treatments (such as cognitive behavioral therapy and deep brain stimulation), and other as yet experimental strategies.

• Authors: Michael Samuel, Maria Rodriguez-Oroz, Angelo Antonini, Jonathan M Brotchie, Kallol Ray Chaudhuri, Richard G Brown, Wendy R Galpern, Melissa J Nirenberg, Michael S Okun, Anthony E Lang
• Journal: Movement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 30 Issue 2 Pg. 150-9 (Feb 2015) ISSN: 1531-8257 [Electronic] United States
• PMID: 25607799 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2015 International Parkinson and Movement Disorder Society.

Chemical References

• Antiparkinson Agents
• Dopamine Agonists

Topics

• Animals
• Antiparkinson Agents (therapeutic use)
• Deep Brain Stimulation (methods)
• Disruptive, Impulse Control, and Conduct Disorders (complications, therapy)
• Dopamine Agonists (therapeutic use)
• Humans
• Impulsive Behavior (drug effects, physiology)
• Parkinson Disease (complications, therapy)